Back to Search
Start Over
Photoactivation of Diiodido-Pt(IV) Complexes Coupled to Upconverting Nanoparticles
- Source :
- Molecular pharmaceutics, 13 (2016): 2346–2362. doi:10.1021/acs.molpharmaceut.6b00108, info:cnr-pdr/source/autori:Perfahl S.; Natile M.M.; Mohamad H.S.; Helm C.A.; Schulzke C.; Natile G.; Bednarski P.J./titolo:Photoactivation of Diiodido-Pt(IV) Complexes Coupled to Upconverting Nanoparticles/doi:10.1021%2Facs.molpharmaceut.6b00108/rivista:Molecular pharmaceutics (Print)/anno:2016/pagina_da:2346/pagina_a:2362/intervallo_pagine:2346–2362/volume:13
- Publication Year :
- 2016
- Publisher :
- American Chemical Society, Washington, DC , Stati Uniti d'America, 2016.
-
Abstract
- The preparation, characterization, and surface modification of upconverting lanthanide-doped hexagonal NaGdF4 nanocrystals attached to light sensitive diiodido Pt(IV) complexes is presented. The evaluation for photo activation and cytotoxicity of the novel carboxylated diiodido Pt(IV) cytotoxic prodrugs by near-infrared (NIR) light (2 = 980 nm) is also reported. We attempted two different strategies for attachment of light-sensitive diiodido Pt(IV) complexes to Yb,Er- and Yb,Tm-doped beta-NaGdF4 upconverting nanoparticles (UCNPs) in order to provide nanohybrids, which offer unique opportunities for selective drug activation within the tumor cells and subsequent spatiotemporal controlled drug release by NIR-to-visible light-upconversion: (A) covalent attachment of the Pt(IV) complex via amide bond formation and (B) carboxylate exchange of oleate on the surface of the UCNPs with diiodido Pt(IV) carboxylato complexes. Initial feasibility studies showed that NIR applied by a 980 nm laser had only a slight effect on the stability of the various diiodido Pt(IV) complexes, but when UCNPs were present more rapid loss of the ligand metal charge transfer (LMCT) bands of the diiodido Pt(IV) complexes was observed. Furthermore, Pt released from the Pt(IV) complexes platinated calf-thymus DNA (ct-DNA) more rapidly when NIR was applied compared to dark controls. Of the two attachment strategies, method A with the covalently attached diiodido Pt(IV) carboxylates via amide bond formation proved to be the most effective method for generating UCNPs that release Pt when irradiated with NIR; the released Pt was also able to bind irreversibly to calf thymus DNA. Nonetheless, only ca. 20% of the Pt on the surface of the UCNPs was in the Pt(IV) oxidation state, the rest was Pt(II), indicating chemical reduction of the diiodido Pt(IV) prodrug by the UCNPs. Cytotoxicity studies with the various UCNP Pt conjugates and constructs, tested on human leukemia HL60 cells in culture, indicated a substantial increase in cytotoxicity when modified UCNPs were combined with five rounds of 30 min irradiation with NIR compared to dark controls, but NIR alone also had a significant cytotoxic effect at this duration.
- Subjects :
- Organoplatinum Compounds
Photochemistry
Pharmaceutical Science
Antineoplastic Agents
02 engineering and technology
010402 general chemistry
01 natural sciences
chemistry.chemical_compound
Microscopy, Electron, Transmission
X-Ray Diffraction
Cell Line, Tumor
Drug Discovery
Humans
Peptide bond
Prodrugs
Upconverting nanoparticles
Carboxylate
photoactivated chemotherapy
Cytotoxicity
Chemistry
DNA
Prodrug
021001 nanoscience & nanotechnology
0104 chemical sciences
upconverting nanoparticles
Nanocrystal
Covalent bond
photoactivatable Pt complexes
anticancer prodrug
Nanoparticles
Molecular Medicine
Surface modification
0210 nano-technology
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Molecular pharmaceutics, 13 (2016): 2346–2362. doi:10.1021/acs.molpharmaceut.6b00108, info:cnr-pdr/source/autori:Perfahl S.; Natile M.M.; Mohamad H.S.; Helm C.A.; Schulzke C.; Natile G.; Bednarski P.J./titolo:Photoactivation of Diiodido-Pt(IV) Complexes Coupled to Upconverting Nanoparticles/doi:10.1021%2Facs.molpharmaceut.6b00108/rivista:Molecular pharmaceutics (Print)/anno:2016/pagina_da:2346/pagina_a:2362/intervallo_pagine:2346–2362/volume:13
- Accession number :
- edsair.doi.dedup.....0dfdb5872166e37c8e8fee73ef76127c
- Full Text :
- https://doi.org/10.1021/acs.molpharmaceut.6b00108